# Michael Nassif – FDA Inspection, Feb 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/michael-nassif/e5886741-f101-4637-b448-21628ed8aa43
Source feed: FDA_Inspections

> FDA inspection 1264110 of Michael Nassif, February 25, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264110
- Company Name: Michael Nassif
- Inspection Date: 2025-02-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/carmen-y-fisher/d41b9f1a-1a29-4b1c-bd64-acedde50302a)

Company: https://www.keypedia.com/companies/michael-nassif/14c08990-1da3-493c-a2d7-5525b31abcc4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c